DIFFERENTIAL ROLES OF MAC-1+ CELLS, AND CD4+ AND CD8+ LYMPHOCYTES-T IN PRIMARY NONFUNCTION AND CLASSIC REJECTION OF ISLET ALLOGRAFTS

被引:189
作者
KAUFMAN, DB
PLATT, JL
RABE, FL
DUNN, DL
BACH, FH
SUTHERLAND, DER
机构
[1] UNIV MINNESOTA, SCH MED, DEPT CELL BIOL & NEUROANAT, MINNEAPOLIS, MN 55455 USA
[2] UNIV MINNESOTA, SCH MED, DEPT SURG, MINNEAPOLIS, MN 55455 USA
[3] UNIV MINNESOTA, SCH MED, DEPT PEDIAT, MINNEAPOLIS, MN 55455 USA
关键词
D O I
10.1084/jem.172.1.291
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The high rate of persistent hyperglycemia, termed primary nonfunction, after islet allotransplantation in C57BL/6 mice recipients of B10.BR strain islets, as compared with B10.BR recipients of C57BL/6 islets, led to a series of experiments to determine whether islet allograft primary nonfunction was attributable to technical aspects of the transplant procedure or whether it was a consequence of alloimmunity. Primary nonfunction was prevented by systemic pharmacologic immunosuppression of the host with cyclosporine. Selective immunodepletion of host CD4+ and CD8+ T lymphocytes significantly extended the time of classic rejection but did not significantly affect the rate of primary nonfunction. However, modulation of macrophages by administration to the host of silica completely abolished primary nonfunction. These observations, in conjunction with the immunnhistological findings of intense macrophage infiltration in islet allografts from recipients exhibiting persistent post-transplant hyperglycemia, support the hypothesis that primary nonfunction results from a cell-mediated host-immune response of rapid onset that is dependent on macrophages or macrophage byproducts as the main effectors. © 1990, Rockefeller University Press., All rights reserved.
引用
收藏
页码:291 / 302
页数:12
相关论文
共 42 条
[21]   REJECTION OF BONE-MARROW ALLOGRAFTS BY MICE WITH SEVERE COMBINED IMMUNE-DEFICIENCY (SCID) - EVIDENCE THAT NATURAL-KILLER-CELLS CAN MEDIATE THE SPECIFICITY OF MARROW GRAFT-REJECTION [J].
MURPHY, WJ ;
KUMAR, V ;
BENNETT, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (04) :1212-1217
[22]   TOTAL OR NEAR TOTAL PANCREATECTOMY AND ISLET AUTO-TRANSPLANTATION FOR TREATMENT OF CHRONIC-PANCREATITIS [J].
NAJARIAN, JS ;
SUTHERLAND, DER ;
BAUMGARTNER, D ;
BURKE, B ;
RYNASIEWICZ, JJ ;
MATAS, AJ ;
GOETZ, FC .
ANNALS OF SURGERY, 1980, 192 (04) :526-542
[23]  
NERSTROM B, 1972, Scandinavian Journal of Urology and Nephrology Supplementum, V6, P65, DOI 10.3109/00365597209133647
[24]   INTERSTITIAL MONONUCLEAR CELL-POPULATIONS IN RENAL GRAFT-REJECTION - IDENTIFICATION BY MONOCLONAL-ANTIBODIES IN TISSUE-SECTIONS [J].
PLATT, JL ;
LEBIEN, TW ;
MICHAEL, AF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (01) :17-30
[25]   RETARDATION OF FADING AND ENHANCEMENT OF INTENSITY OF IMMUNOFLUORESCENCE BY PARA-PHENYLENEDIAMINE [J].
PLATT, JL ;
MICHAEL, AF .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1983, 31 (06) :840-842
[26]   DESTRUCTION OF RAT ISLET CELL MONOLAYERS BY CYTOKINES - SYNERGISTIC INTERACTIONS OF INTERFERON-GAMMA, TUMOR NECROSIS FACTOR, LYMPHOTOXIN, AND INTERLEUKIN-1 [J].
PUKEL, C ;
BAQUERIZO, H ;
RABINOVITCH, A .
DIABETES, 1988, 37 (01) :133-136
[27]   INHIBITORY EFFECTS OF INTERLEUKIN-1 ON INSULIN-SECRETION, INSULIN-BIOSYNTHESIS, AND OXIDATIVE-METABOLISM OF ISOLATED RAT PANCREATIC-ISLETS [J].
SANDLER, S ;
ANDERSSON, A ;
HELLERSTROM, C .
ENDOCRINOLOGY, 1987, 121 (04) :1424-1431
[28]   CLONED LYMPHOCYTES-T AND MONOCLONAL-ANTIBODIES AS PROBES FOR CELL-SURFACE MOLECULES ACTIVE IN T-CELL-MEDIATED CYTOLYSIS [J].
SARMIENTO, M ;
DIALYNAS, DP ;
LANCKI, DW ;
WALL, KA ;
LORBER, MI ;
LOKEN, MR ;
FITCH, FW .
IMMUNOLOGICAL REVIEWS, 1982, 68 :135-169
[29]  
SCHARP D, 1989, TRANSPLANT P, V21, P2744
[30]  
SCHARP DW, 1985, DIABETES S1, V34, pA5